PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmacy Department, Saint Barnabas Medical Center, 94 Old Short Hills Road, Livingston, NJ 07039, USA. Electronic address: steven.smoke@rwjbh.org.\', \'Pharmacy Department, Clara Maass Medical Center, 1 Clara Maass Dr., Belleville, NJ 07109, USA. Electronic address: karan.raja@rwjbh.org.\', \'Biostatistics Department, Saint Barnabas Medical Center, Livingston, NJ, USA.\', \'Pharmacy Department, Clara Maass Medical Center, 1 Clara Maass Dr., Belleville, NJ 07109, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0924-8579(20)30485-410.1016/j.ijantimicag.2020.106265
?:hasPublicationType
?:journal
  • International journal of antimicrobial agents
is ?:pmid of
?:pmid
?:pmid
  • 33338559
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 107
is ?:relation_isRelatedTo_publication of
?:title
  • Early clinical outcomes with tocilizumab for severe COVID-19: a two-centre retrospective study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all